DISEASE MARKERS

友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。

期刊名

DISEASE MARKERS

DIS MARKERS

ISSN / eISSN

0278-0240 / 1875-8630

目标和范围

Disease Markers is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the identification of disease markers, the elucidation of their role and mechanism, as well as their application in the prognosis, diagnosis and treatment of diseases.

研究方向

N/A

CiteScore

3.70

查看趋势图

CiteScore 学科排名

类别	分区	排名
Medicine - Biochemistry (medical)	Q3	#36/65
Medicine - Genetics	Q3	#211/328
Medicine - Clinical Biochemistry	Q3	#79/113
Medicine - Molecular Biology	Q3	#281/380

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
-	-

H-index

出版国家或地区

NETHERLANDS

出版商

Hindawi Limited

出版周期

Bimonthly

出版年份

1983

年文章数

241

Open Access

YES

通讯方式

IOS PRESS, NIEUWE HEMWEG 6B, AMSTERDAM, NETHERLANDS, 1013 BG

同领域相关热门期刊
近期发表文章

Exploration of Metabolite Biomarkers to Predict the Efficacy of Dupilumab Treatment for Atopic Dermatitis: (2023) Shoko Miyamoto, Yasutomo Imai, Masako Matsutani, Makoto Nagai, Kiyofumi Yamanishi, Nobuo Kanazawa, Shin Nishiumi

Retracted: Neurotransmitters and Electrophysiological Changes Might Work as Biomarkers for Diagnosing Affective Disorders: (2023) Disease Markers

Meta-Analysis of Assessment of Total Oxidative Stress and Total Antioxidant Capacity in Patients with Periodontitis: (2023) Khadijah Mohideen, Krithika Chandrasekaran, Harsha Veeraraghavan, Shahul Hameed Faizee, Safal Dhungel, Snehashish Ghosh

Retracted: Bioinformatics Analysis Identifies ASCL1 as the Key Transcription Factor in Hepatocellular Carcinoma Progression: (2023) Disease Markers

Insights into the Role of Galectin-3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation: (2023) Yasmin Mohtasham Kia, Alessandro Cannavo, Pegah Bahiraie, Sanam Alilou, Behrad Saeedian, Nastaran Babajani, Elina Ghondaghsaz, Amirmohammad Khalaji, A...

Correlation Analysis of Prognostic Gene Expression, Tumor Microenvironment, and Tumor-Infiltrating Immune Cells in Ovarian Cancer: (2023) Qing Li, Zongjing Yang, Xingqing Ling, Junming Ye, Jiaying Wu, Yu Wang, Chun Yao, Jinghui Zheng

Retracted: CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4: (2023) Disease Markers

Retracted: Expression Profile and Prognostic Values of CDH Family Members in Lung Adenocarcinoma: (2023) Disease Markers

Retracted: Qing Zao Fang (QZF) Alleviates the Inflammatory Microenvironment of the Submandibular Gland in Sjögren’s Syndrome Based on the PI3K/Akt/HIF-1α/VEGF Signaling Pathway: (2023) Disease Markers

hsa_circ_0129047 Upregulates LYVE1 to Inhibit Hepatocellular Carcinoma Progression by Sponging miR-492: (2023) Zhenzhen Feng, Jiyuan Wu

认证评论

注：认证评论选取于全球各个学术评论平台和社交媒体。

Can you please reject the manuscript faster? It has been hanging for 3 months without being assigned for initial review, and then the initial review takes nearly another month. I estimate that it takes about half a month for the initial reviewer to even take a glance at the manuscript. It only took a month to reject the revised manuscript!

2022-08-03

After more than a month of initial review, I made significant revisions and resubmitted the article. It was basically accepted. I submitted a clinical retrospective article, and this journal does not have too many publications, so it is relatively niche. Overall, it is fine, and the review requirements are not too strict.

2022-06-25

查看所有评论

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started